---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-004016"
form_type: "8-K"
ticker: "BBNX"
cik: "0001674632"
company_name: "Beta Bionics, Inc."
filed_at: "2025-06-23T23:59:59+00:00"
generated_at: "2026-05-18T23:51:49.709128+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Beta Bionics reports real-world iLet data: HbA1c drops from 8.9% to 7.3% in 14,952 users

## Summary
- 16,439 iLet users uploaded data in first 2 years; 14,952 with baseline HbA1c showed avg drop from 8.9% to 7.3% GMI.
- 8,802 prior MDI users improved from 9.2% to 7.3%; 2,910 prior HCL users improved from 8.1% to 7.3%.
- 2,416 'fully-closed loop' users (≤1 meal announcement/day) improved from 9.4% to 7.5% GMI; 83% met ADA hypoglycemia goals.
- Adaptive algorithm reaches steady state in ~2 days; similar outcomes seen in primary care and endocrinology practices.
- Company highlights pharmacy channel strategy and bionic portal for HCPs; no financial guidance provided.

## SEC filing metadata
- accession: 0001171843-25-004016
- form_type: 8-K
- ticker: BBNX
- cik: 0001674632
- company_name: Beta Bionics, Inc.
- filed_at: 2025-06-23T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674632/000117184325004016/0001171843-25-004016-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674632/000117184325004016/f8k_062225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-004016
- JSON: https://secwatch.observer/filing/0001171843-25-004016.json
- Plain text: https://secwatch.observer/filing/0001171843-25-004016.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.